Here, you can get an overview of the already confirmed speakers for the 2026 conference. More information will be added gradually.
Keynote Speakers
Stephane Bancel
Cambridge, USA
Talk title:
mRNA 2.0: The Race to Learn Faster
Feng Zhang
Cambridge, USA
Talk title:
Exploration of Biological Diversity
Karen Beets
Niel, Belgium
Talk title:
Autoantigen mRNA-LNP vaccination drives therapeutic efficacy in preclinical models for autoimmunity
David Berman
Cambridge, USA
Talk title:
Individualized neoantigen therapy
Kimberly Bockley
Baltimore, USA
Talk title:
Lipid nanoparticle mediated delivery of therapeutic mRNA for the treatment of obstetric conditions
Brian Brown
New York City, USA
Talk title:
Investigating the role of muscle, liver, and DCs in mRNA vaccine immunogenicity
Natasha Chaudhary
Brisbane, Australia
Talk title:
The Bicycle Reaction: A Single-Pot, Cell-Free Platform for Streamlined mRNA Medicine Manufacture
John P. Cooke
Houston, USA
Talk title:
Establishing a Personalized Cancer Vaccine Platform in a Hospital Setting: From Development to Clinical Deployment
Davide De Lucrezia
Talk title:
From Melody to Symphony: Tuning mRNA for Peak Performance
Gilles Divita
Pacific Palisades, USA
Talk title:
In vivo mRNA CAR-T cell engineering using peptide based nanoparticles targeting CD3 or CD8
Wayne Doyle
San Diego, USA
Talk title:
Lab-in-the-Loop: Closing the Design-Build-Test Gap in mRNA Development
Patrik Engström
San Diego, USA
Talk title:
Choosing the Right Enzyme for RNA Manufacturing and Therapeutics
Emily Freund
Palo Alto, USA
Talk title:
A novel engineered T7 RNA polymerase produces therapeutic mRNA
May Guo
Boston, USA
Talk title:
Innovation in Enzymes and Assays for mRNA Manufacturing
Akash Gupta
Houston, USA
Talk title:
mRNA-LNP-Mediated Immunomodulation for Precision Cancer Vaccines and Immunotherapy
Michael Hogan
Philadelphia, USA
Talk title:
Investigating the role of IL-1 signaling in reactogenicity and immunogenicity of clinical mRNA-LNP vaccines in mice
Keiji Itaka
Osaka, Japan
Talk title:
mRNA Cocktail Therapy for Ischemic Heart Disease: A Novel Approach Using Polyplex Nanomicelle
Ruaidhrí Jackson
Boston, USA
Sabah Kasmi
Zwijnaarde, Belgium
Talk title:
Engineering Lipid Nanoparticles for Efficient In Vivo Genome Editing of Hematopoietic Stem Cells
Myeonghwan Kim
Seoul, South Korea
Talk title:
Tailon technology enables low-dose, durable protein expression for infrequent enzyme replacement therapy
Ben Kleinstiver
Boston, USA
Talk title:
From bespoke to more universal genome editing treatments
Bowen Li
Toronto, Canada
Xiang Liu
Michigan, USA
Talk title:
Programming Antigen Fate in mRNA Vaccines Potentiates Cancer Immunotherapy
Tyson Lobb
St. Louis, USA
Talk title:
Unraveling the Role of Type I Interferon Signaling During mRNA Vaccination
Duccio Medini
Pittsburgh, USA
Talk title:
A Universal AI Design Framework and Brokerage Platform for Democratised Manufacturing of mRNA Therapeutics
Michael Mitchell
Philadelphia, USA
Jorge Rodrigo Mora
Brisbane, USA
Talk title:
A novel hydrophilic nanoparticle mRNA-based platform to induce immune tolerance in autoimmune diseases
Yunsun Nam
Dallas, USA
Talk title:
Substrate selectivity of the human RNA m5C methyltransferase NSUN2
Kevin Ou
Vancouver, Canada
Lívia Palmerston Mendes
Vancouver, Canada
Talk title:
Challenging the PEG Paradigm: Stable Unshielded Lipid Nanoparticles Enable Potent Extrahepatic Delivery
Anna Marie Pyle
Connecticut, USA
Shu-Bing Qian
Ithaca, USA
Talk title:
Programmable mRNA translation initiation by trans-RNA
Liang Qu
Shanghai, China
Talk title:
Nucleoside-modified CircRNA and Chemically-synthesized RNA Vaccine
Manan Rajith Singh
Cambridge, USA
Talk title:
AI-Guided Discovery of Biodegradable Lipid Nanoparticles for Liver mRNA Delivery and Pulmonary Genome Editing
Hagen Richter
Munich, Germany
Talk title:
Closing the gap, R&D meets GMP
Gaurav Sahay
Portland, USA
Talk title:
Chasing the Elusive Escape: Measuring Endosomal Trafficking In Vivo to Build Better Lipid Nanoparticles
Rok Sekirnik
Ajdovščina, Slovenia
Talk title:
Increasing mRNA Yield Without Increasing Complexity
Xiangrong Song
Chengdu, China
Talk title:
Advancing LNP Systems for Clinical Development of mRNA-based Medicines
Christopher Stach
Boston, USA
Talk title:
Codon optimization and AI-guided 5′UTR generation for enhanced mRNA expression
Ying Tam
Vancouver, Canada
Talk title:
Advancing LNP Systems for Clinical Development of mRNA-based Medicines
Luke Timoldi
Burlington, USA
Hamid Trimech
Tokyo, Japan
Talk title:
Establishing DS/DP End-to-End Manufacturing Capability of mRNA Vaccines and Therapeutics
Srivats Venkataramanan
Emeryville, USA
Talk title:
First principles design of PRINT™, a new class of RNA medicines for durable genomic integration
Naoki Yamada
Cambridge, USA
Talk title:
Beyond the Liver: Well-Tolerated Novel Lipid and Ready to Use LNP Expanding mRNA Therapeutic Applications
Tomoyoshi Yamano
Kanazawa, Ishikawa, Japan
Talk title:
A modular mRNA platform for in vivo induction of antigen-specific immune tolerance
Ed Yaworski
Basel, Switzerland
Talk title:
Innovative biodegradable lipids enable potent and safe delivery of nucleic acid therapeutics